U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
116761116761Safety and Efficacy Study of EXC 001 to Improve the Appearance of Scars From Prior Breast SurgeryCompletedNo Results AvailableScar PreventionDrug: EXC 001|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01037413
116762116762Biochemical Approach to Measuring Surgical TraumaWithdrawnNo Results AvailableTotal Knee Replacementhttps://ClinicalTrials.gov/show/NCT01037400
116763116763Effect of Noninvasive Ventilation on Physical Activity and Inflammation in COPD PatientsRecruitingNo Results AvailableChronic Obstructive Pulmonary Disease|HypercapnicDrug: Control|Device: NIMV grouphttps://ClinicalTrials.gov/show/NCT01037387
116764116764Anticipation of the Difficult Airway: the Preoperative Airway Assessment FormCompletedNo Results AvailableEndotracheal Intubation Risk AssessmentOther: Preoperative assessment formhttps://ClinicalTrials.gov/show/NCT01037374
116765116765Cerebral Activity Related to Primary Motor Stereotypies in Children: An EEG Study.CompletedNo Results AvailableMovement Disorderhttps://ClinicalTrials.gov/show/NCT01037361
116766116766Ranibizumab for the Treatment of Choroidal Neovascularisation (CNV) Secondary to Pathological Myopia (PM): an Individualized RegimenCompletedNo Results AvailableChoroidal NeovascularisationDrug: ranibizumab 0.5mghttps://ClinicalTrials.gov/show/NCT01037348
116767116767Effect of Local Administration of Morphine for Analgesia After Iliac Bone Graft HarvestRecruitingNo Results AvailableAutogenous Bone GraftsDrug: morphinehttps://ClinicalTrials.gov/show/NCT01037335
116768116768Cannabidiol for Inflammatory Bowel DiseaseCompletedNo Results AvailableCrohn's Disease|Ulcerative ColitisDrug: cannabidiol|Drug: placebo in dropshttps://ClinicalTrials.gov/show/NCT01037322
116769116769Phase I/II Study of PRO044 in Duchenne Muscular Dystrophy (DMD)CompletedHas ResultsDuchenne Muscular DystrophyDrug: PRO044 SC|Drug: PRO044 IVhttps://ClinicalTrials.gov/show/NCT01037309
116770116770Catheter Ablation of Atrial Fibrillation Using Hansen Medical Robotic NavigationTerminatedNo Results AvailableAtrial FibrillationProcedure: catheter ablation|Procedure: catheter ablationhttps://ClinicalTrials.gov/show/NCT01037296
116771116771Interpersonal and Social Rhythm Therapy Enter the Brief Title for Protocol IRB 09-003781>CompletedNo Results AvailableBipolar Disorder, DepressedBehavioral: Interpersonal and Social Rhythm Therapyhttps://ClinicalTrials.gov/show/NCT01037283
116772116772Evaluation of the Accuracy and Precision of the INRatio® Prothrombin Time (PT) Monitoring System With New INRatio Test Strip Designed for Low Sample Volume and Heparin InsensitivityCompletedNo Results AvailablePulmonary Embolism|Atrial Fibrillation|Deep Vein Thrombosishttps://ClinicalTrials.gov/show/NCT01037270
116773116773Treatment of Erectile Dysfunction ICompletedHas ResultsErectile DysfunctionDrug: Udenafil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01037244
116774116774Phase 2/3 Oxabact StudyCompletedNo Results AvailablePrimary HyperoxaluriaBiological: Oxalobacter formigenes|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01037231
116775116775Treatment of Erectile Dysfunction IICompletedHas ResultsErectile DysfunctionDrug: Udenafil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01037218
116776116776Randomized, Double-blind, Placebo Controlled Phase II Study to Examine the Effects of DAS181 in Healthy Adult Subjects With Laboratory Confirmed InfluenzaCompletedNo Results AvailableInfluenzaDrug: DAS181 dry powder, formulation F02|Drug: Respitose ML006 (DMV-Fonterra)https://ClinicalTrials.gov/show/NCT01037205
116777116777Evaluating the Use of Large-dose, Extended Interval Vancomycin Intravenous Administration for Skin and Soft Tissue InfectionsCompletedHas ResultsSkin and Soft Tissue InfectionsDrug: vancomycin|Drug: vancomycinhttps://ClinicalTrials.gov/show/NCT01037192
116778116778An Open-Label, Long-Term Study With AL-4943A Ophthalmic Solution, 0.2% in Patients With Allergic ConjunctivitisCompletedNo Results AvailableAllergic ConjunctivitisDrug: Olopatadine Hydrochloride Ophthalmic Solution, 0.2%https://ClinicalTrials.gov/show/NCT01037179
116779116779Study in Japan of the Safety And Antiviral Activity in Adults With Chronic Hepatitis B Current Lamivudine TherapyCompletedNo Results AvailableChronic Hepatitis BDrug: Entecavirhttps://ClinicalTrials.gov/show/NCT01037166
116780116780Effects of Nicotine on Brain Activity as Measured by fMRICompletedNo Results AvailableNicotine Dependence|Drug Abusehttps://ClinicalTrials.gov/show/NCT01037153
116781116781Effects of Vitamin D Supplementation in ObesityCompletedNo Results AvailableVitamin D Deficiency|ObesityDrug: Cholecalciferol|Drug: placebohttps://ClinicalTrials.gov/show/NCT01037140
116782116782Study to Determine the Effectiveness of GSK1120212 in BRAF Mutation-positive Melanoma Previously Treated With or Without a BRAF InhibitorCompletedHas ResultsCancerDrug: GSK1120212https://ClinicalTrials.gov/show/NCT01037127
116783116783Long-term Persistence Study in Healthy Adults Previously Vaccinated With TwinrixTM AdultActive, not recruitingHas ResultsHepatitis A|Hepatitis BProcedure: Blood sampling|Biological: EngerixTM-B|Biological: Havrixhttps://ClinicalTrials.gov/show/NCT01037114
116784116784D-Cycloserine-Enhancer of One-Session Treatment for Phobia of HeightsRecruitingNo Results AvailableHeight PhobiaBehavioral: In Vivo Exposure Therapy|Behavioral: Virtual Reality Exposure Therapy|Drug: D-Cycloserine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT01037101
116785116785Effects of Vaporized Marijuana on Neuropathic PainCompletedHas ResultsNeuropathic Pain|Reflex Sympathetic Dystrophy|Peripheral Neuropathy|Post-herpetic Neuralgia|Spinal Cord Injury|Multiple SclerosisDrug: Cannabis|Drug: Cannabis|Drug: Cannabishttps://ClinicalTrials.gov/show/NCT01037088
116786116786Influence of Nicotine on Cognitive Function in Schizophrenic Patients With and Without Comorbid Drug DependenceCompletedNo Results AvailableSchizophrenia|Drug Abuse/Dependencyhttps://ClinicalTrials.gov/show/NCT01037075
116787116787An Open-Label Rollover Study of Entecavir (BMS-200475) in Adults With Chronic Hepatitis B InfectionCompletedNo Results AvailableChronic Hepatitis BDrug: Entecavirhttps://ClinicalTrials.gov/show/NCT01037062
116788116788Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 WeeksActive, not recruitingNo Results AvailableAdenocarcinoma of the Rectum|Adenocarcinoma|Adenocarcinoma, Mucinous|Carcinoma|Neoplasms, Glandular and Epithelial|Neoplasms by Histologic Type|Neoplasms|Neoplasms, Cystic, Mucinous, and Serous|Colorectal Neoplasms|Intestinal Neoplasms|Gastrointestinal NeOther: Patients who have surgery at 12 weeks after radiotherapy/chemoradiotherapyhttps://ClinicalTrials.gov/show/NCT01037049
116789116789A Study of the L-PPDS With Adjunctive Xalatan® Eye Drops in Subjects With OH or OAGCompletedNo Results AvailableOcular Hypertension|Open-Angle GlaucomaDrug: Latanoprost Punctal Plug Delivery System|Drug: Xalatanhttps://ClinicalTrials.gov/show/NCT01037036
116790116790Regulatory Hycamtin(Oral) PMSCompletedNo Results AvailableLung Cancer, Small CellDrug: Topotecanhttps://ClinicalTrials.gov/show/NCT01037023

* Görseller ve İçerik tekif hakkına sahip olabilir